Swedish and Italian researchers build a tumor model on a chip with nerves
The stamp-sized device replicates the microenvironment of head and neck cancer to study tumor spread and test chemotherapy outside living organisms.
By Letizia Giugliano
3 min readWritten with AI support · Reviewed and approved by: Letizia Giugliano

Researchers at Linköping University in Sweden and Politecnico di Milano in Italy have engineered an organ-on-a-chip that replicates how solid tumors interact with nerves and blood vessels. Built on a plate roughly the size of a postage stamp, the invention provides a controlled microsystem to examine how cancer cells move, grow, and respond to chemotherapy.
Rebuilding the tumor microenvironment on a stamp
In the human body, tumors do not exist in isolation. They expand within a complex network of tissues, nerves, and circulatory channels known as the extracellular matrix (ECM). To study these interactions outside the human body, a team led by senior associate professor Pierfrancesco Pagella at Linköping University developed a three-step bioengineered innovation, published in the journal Proceedings of the National Academy of Sciences.
The platform mimics the natural matrix using a mix of hyaluronic acid, collagen, and laminins. The researchers found that altering this matrix composition directly influenced how cancer cells behaved and how vulnerable they remained to chemical treatments, showing that the physical scaffold around a tumor dictates its development.
Photo: Brecht Corbeel / Unsplash
“Rather than having to carry out research on animals or test potential drugs in humans, we want to be able to carry out tests in a single microsystem in the laboratory.”
— Pierfrancesco Pagella, senior associate professor at Linköping University
Tracking cancer cells as they hunt blood vessels
The second phase of the system added artificial blood vessel channels. Blood vessels deliver oxygen and nutrients to growing cells, but they also serve as the main highway for metastatic cancer cells seeking new sites in the body. When introduced to the microfluidic plate, the cancer cells reacted immediately, moving toward the vascular structures and invading them.
The team then applied cisplatin, a standard chemotherapy medicine used against head and neck cancer, directly through the artificial bloodstream on the chip. The tests confirmed that the surrounding matrix material directly influenced how effectively the drug killed the malignant cells, offering an experimental testbed for future oncology drug screening.
Stem cells recreate facial pain and nerve connections
To complete the bioengineered setup, the researchers used stem cells to reconstruct trigeminal ganglia, which are the nerve clusters responsible for sensation and pain in the human face and mouth. Within several days on the chip, nerve fibers extended outward and wrapped around the cancer tissue.
The resulting observations revealed an unexpected biological trade-off. Tumors touching the nerves grew larger, yet they were less likely to invade the nearby blood vessels. This finding gives oncologists a new look at cancer-related pain and tumor behavior in head and neck malignancies, where nervous tissue plays an active biological role.
Next steps in microfluidic drug screening
The microfluidic device was designed together with the MiMic Lab at Politecnico di Milano, led by Professor Marco Rasponi, chair of the European Organ-on-Chip Society. By avoiding animal testing, the team aims to establish controlled laboratory assays that can test individual drug responses before clinical treatments begin.
The research group plans to adapt the chip architecture to examine other solid tumor varieties where interactions with nerves and blood supply govern treatment resistance. The study authors anticipate that this invention could serve as a testing platform for custom cancer therapies, paving the way for future patent protection and clinical development.
Read also on The Patent: Australian Federal Court Clears Samsung Bioepis in Pfizer Enbrel Patent Dispute · UT Southwestern designs versatile 3D microscope for live cell imaging
An article by the newsroom of The Patent ®, written with the support of artificial intelligence from sources chosen by the newsroom. Review, corrections and approval for publication: Letizia Giugliano. Publisher responsible: WitUp Ltd.



